Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis

被引:37
|
作者
Lundtoft, Christian [1 ]
Awuah, Anthony Afum-Adjei [2 ,3 ]
Rimpler, Jens [1 ]
Harling, Kirstin [1 ]
Nausch, Norman [1 ]
Kohns, Malte [1 ]
Adankwah, Ernest [1 ]
Lang, Franziska [1 ]
Olbrich, Laura [1 ]
Mayatepek, Ertan [1 ]
Owusu-Dabo, Ellis [2 ,3 ]
Jacobsen, Marc [1 ]
机构
[1] Univ Childrens Hosp, Med Fac, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany
[2] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana
[3] KNUST, Sch Med Sci, Kumasi, Ghana
关键词
HIV-INFECTED PATIENTS; ACTIVE PULMONARY TUBERCULOSIS; CHRONIC VIRAL-INFECTION; INTERLEUKIN-7; RECEPTOR; ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; CD127; EXPRESSION; INFLAMMATORY CYTOKINES; MULTIPLE-SCLEROSIS; IMMUNE ACTIVATION;
D O I
10.1371/journal.ppat.1006425
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
T-cell proliferation and generation of protective memory during chronic infections depend on Interleukin-7 (IL-7) availability and receptivity. Regulation of IL-7 receptor (IL-7R) expression and signalling are key for IL-7-modulated T-cell functions. Aberrant expression of soluble (s) and membrane-associated (m) IL-7R molecules is associated with development of autoimmunity and immune failure in acquired immune deficiency syndrome (AIDS) patients. Here we investigated the role of IL-7/IL-7R on T-cell immunity in human tuberculosis. We performed two independent case-control studies comparing tuberculosis patients and healthy contacts. This was combined with follow-up examinations for a subgroup of tuberculosis patients under therapy and recovery. Blood plasma and T cells were characterised for IL-7/sIL-7R and mIL-7R expression, respectively. IL-7-dependent T-cell functions were determined by analysing STAT5 phosphorylation, antigen-specific cytokine release and by analysing markers of T-cell exhaustion and inflammation. Tuberculosis patients had lower soluble IL-7R (p < 0.001) and higher IL-7 (p < 0.001) plasma concentrations as compared to healthy contacts. Both markers were largely independent and aberrant expression normalised during therapy and recovery. Furthermore, tuberculosis patients had lower levels of mIL-7R in T cells caused by post-transcriptional mechanisms. Functional in vitro tests indicated diminished IL-7-induced STAT5 phosphorylation and impaired IL-7-promoted cytokine release of Mycobacterium tuberculosis-specific CD4(+) T cells from tuberculosis patients. Finally, we determined T-cell exhaustion markers PD-1 and SOCS3 and detected increased SOCS3 expression during therapy. Only moderate correlation of PD-1 and SOCS3 with IL-7 expression was observed. We conclude that diminished soluble IL-7R and increased IL-7 plasma concentrations, as well as decreased membrane-associated IL-7R expression in T cells, reflect impaired T-cell sensitivity to IL-7 in tuberculosis patients. These findings show similarities to pathognomonic features of impaired T-cell functions and immune failure described in AIDS patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy
    Dower, William J.
    Park, Angie Inkyung
    Bakker, Alice V.
    Cwirla, Steven E.
    Pongtornpipat, Praechompoo
    Williams, Blake M.
    Joshi, Prarthana
    Baxter, Bryan A.
    Needels, Michael C.
    Barrett, Ronald W.
    PLOS ONE, 2023, 18 (10):
  • [32] IL-7 in human health and disease
    Lundstroem, Wangko
    Fewkes, Natasha M.
    Mackall, Crystal L.
    SEMINARS IN IMMUNOLOGY, 2012, 24 (03) : 218 - 224
  • [33] Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life
    Nasi, M
    Troiano, L
    Lugli, E
    Pinti, M
    Ferraresi, R
    Monterastelli, E
    Mussi, C
    Salvioli, G
    Franceschi, C
    Cossarizza, A
    AGING CELL, 2006, 5 (02) : 167 - 175
  • [34] IL-7-neutralizing antibody enhances in vivo IL-7 activity by interfering with normal IL-7 clearance
    Martin, Chris
    Surh, Charles
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [35] HUMAN IL-7 - A NOVEL T-CELL GROWTH-FACTOR
    WELCH, PA
    NAMEN, AE
    GOODWIN, RG
    ARMITAGE, R
    COOPER, MD
    JOURNAL OF IMMUNOLOGY, 1989, 143 (11): : 3562 - 3567
  • [36] IL-7 accelerates human T-Cell leukemia progression in vivo
    Silva, Ana
    Seddon, Ben
    Barata, Joao T.
    CYTOKINE, 2009, 48 (1-2) : 127 - 127
  • [37] The IL-7/IL-7 receptor axis: Understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy
    Sasson, Sarah C.
    Zaunders, John J.
    Kelleher, Anthony D.
    CURRENT DRUG TARGETS, 2006, 7 (12) : 1571 - 1582
  • [38] Interleukin 2 (IL-2) and interleukin 7 (IL-7) reciprocally induce IL-7 and IL-2 receptors on gamma delta T-cell receptor-positive intraepithelial lymphocytes
    Fujihashi, K
    Kawabata, S
    Hiroi, T
    Yamamoto, M
    McGhee, JR
    Nishikawa, SI
    Kiyono, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) : 3613 - 3618
  • [39] Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells
    M Moors
    N K Vudattu
    J Abel
    U Krämer
    L Rane
    N Ulfig
    S Ceccatelli
    V Seyfert-Margolies
    E Fritsche
    M J Maeurer
    Genes & Immunity, 2010, 11 : 11 - 20
  • [40] IL-7 goes antiviral
    Yvonne Bordon
    Nature Reviews Immunology, 2011, 11 : 159 - 159